Remove 2026 Remove Clinic Remove Government Remove Manufacturing
article thumbnail

‘MAHA Report’ Calls for Fighting Chronic Disease, but Trump and Kennedy Have Yanked Funding

Physician's Weekly

But the administration is seeking to cut government funding that could serve as a counterweight. Elements of Trump’s proposed budget for the 2026 fiscal year clash with priorities laid out in the MAHA report. government is committed to fostering radical transparency and gold-standard science.”

52
article thumbnail

Decades of LDT Tension Leads to an Epic Three-Hour Oral Argument

FDA Law

On February 19, 2025, Judge Sean Jordan in the Eastern District of Texas heard oral arguments in American Clinical Laboratory Association (ACLA) and the Association for Molecular Pathologys (AMP) [1] lawsuit against the Department of Health and Human Services. Perhaps most notable in yesterdays argument, though, was what didnt happen.

article thumbnail

Drug Pricing Reform Gathers Steam (Part 1): White House Drug Pricing Plan Offers Laundry List of Existing Democrat Priorities

FDA Law

A final OIG rule to change the structure of manufacturer rebates to Medicare Part D and Medicaid Managed Care plans and their PBMs is enmeshed in litigation and is likely to be at least postponed until 2026 (see our post ), and perhaps prevented from implementation altogether, by Congressional mandate.